Offices in Europe, Middle East & Asia +49 176 61255904 Receive an answer in less than 72h
FacebookInstagramLinkedInYouTube

A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4+ and CD8+ T Cells in COVID-19 Patients

Saskia Biskup

Saskia Biskup

A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4+ and CD8+ T Cells in COVID-19 Patients

Henning Zelba, David Worbs, Johannes Harter, Natalia Pieper, Christina Kyzirakos-Feger, Simone Kayser, Marcel Seibold, Oliver Bartsch, Jiri Ködding and Saskia Biskup

J Immunol 2021; 206:580-587
doi: 10.4049/jimmunol.2000811
© 2021 The American Association of Immunologists

A-Highly-Specific-Assay-for-Detection-of-SARS-CoV2–Reactive-CD4-CD8-T-Cells-COV19-Pat-SB

More publications from Saskia Biskup

2021-11-06T11:28:18+01:00November 6, 2021|Other article for therapists|

Share This Story, Choose Your Platform!

FacebookEmail

More insights from Integrative Cancer Care

* required
to receive the latest news from Integrative Cancer Care, including occasional surveys as well as medical publications. I understand that I may opt-out at any time with one click at the bottom of your emails. I have read your privacy policy
ICC Logo White footer

Site Menu

Home
Our approach
Patient journey
Cancer care
Site notice

Tumor board experts
Patient testimonials
Publications
Privacy Policy

Contact

case-manager@integrative-cancer-care.com
+49 176 61255904
Powered by Aeskulap International

ICC Logo White footer

Site Menu

Home
Our approach
Patient journey
Cancer care
Site notice

Tumor board experts
Patient testimonials
Publications
Privacy Policy

Contact

case-manager@integrative-cancer-care.com
+49 176 61255904
Powered by Aeskulap International

ICC Logo White footer

Site Menu

Home
Our approach
Patient journey
Cancer care
Site notice

Tumor board experts
Patient testimonials
Publications
Privacy Policy

Contact

case-manager@integrative-cancer-care.com
+49 176 61255904
Powered by Aeskulap International

© 2021 – 2024 Integrative Cancer Care | FDM

Go to Top